Skip to content

Jazz Pharmaceuticals JAZZ Effective Income Tax Rate Reconciliation, Other Adjustments, Amount

Effective Income Tax Rate Reconciliation, Other Adjustments, Amount at other companies

Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS

Other financials

Income statement

See full
Revenue$1.1B+19.1%
Operating income$336.6M+702%
Net income$293.1M+417%
EPS (diluted)$4.43+391%

Balance sheet

See full
Cash & equivalents$667.5M-64.1%
Total debt$5.4B-0.1%
Total equity$4.5B+8.6%
Total assets$11.9B+2.8%

Cash flow

See full
Operating cash flow$408.2M-5.0%
CapEx$19.7M+41.7%
Free cash flow$388.5M-6.6%

Valuation

See full
Market cap$14.11B+54.4%
Enterprise value$18.85B+47.7%
P/S3.2×+0.9×

Profitability

See full
Operating margin-11.9%-28.1pp
Net margin-8.9%-20.5pp
FCF margin28.6%-8.6pp

Returns & leverage

See full
Return on equity-9.1%-21.2pp
Debt / equity1.2×-0.1×
Current ratio-1.3×

Where this comes from

Reported directly by Jazz Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxReconciliationOtherAdjustments.

The official record: Jazz Pharmaceuticals’s 10-K, filed February 24, 2026, on SEC EDGAR. View the filing →

Ask your AI about Jazz Pharmaceuticals's effective income tax rate reconciliation, other adjustments, amount.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Jazz Pharmaceuticals's effective income tax rate reconciliation, other adjustments, amount?
Jazz Pharmaceuticals (JAZZ) reported effective income tax rate reconciliation, other adjustments, amount of $978.25K in Q4 2024.
How has Jazz Pharmaceuticals's effective income tax rate reconciliation, other adjustments, amount changed year-over-year?
Jazz Pharmaceuticals's effective income tax rate reconciliation, other adjustments, amount increased by 6.9% year-over-year, from $915.25K to $978.25K.
What is the long-term trend for Jazz Pharmaceuticals's effective income tax rate reconciliation, other adjustments, amount?
Over 3 years (2021 to 2024), Jazz Pharmaceuticals's effective income tax rate reconciliation, other adjustments, amount has grown at a 26.6% compound annual growth rate (CAGR), from $1.93M to $3.91M.